Post Reply
61-80 of 1318
Nov 2025 when Zixin was 3.6 cents
TraderBen ( Date: 24-Apr-2026 11:29) Posted:
|
this TP have been her for the longest time..
piscesmonkey ( Date: 24-Apr-2026 11:24) Posted:
|
- Zixin Group Holdings &ndash Action: BUY
- Target Price: S\$0.066 (Current Price: S\$0.032)
- Potential Upside: Over 100%
- Valuation: 5.2x forward PE, 0.5x PB, no dividend
- Key Actionable Idea: Maintain BUY due to strong growth trajectory and expansion in Singapore and Southeast Asia, including new product launches and a JV for fresh produce distribution. Target price is pegged to 10x FY26F PE.
Break 34 then moving up test 39 if break then 40 above
Write a thesis for its SGD7k investment, while its US400k investment in an unrelated co in US buried in a few lines.
It shows the Co.
It shows the Co.
Joelton ( Date: 14-Apr-2026 08:29) Posted:
|
Zixin Group sets up joint venture company with AANDJ Group on fresh agricultural products distribution
Zixin Group (SGX:42W) (Zixin) announced that its wholly-owned subsidiary, Zixin Enterprise (Singapore) Pte Ltd, has established a joint venture company called Zixin Fresh Import & Export Pte Ltd, with AANDJ Group Pte Ltd (AANDJ Group) to embark on the fresh agricultural products distribution business in Singapore, and subsequently neighbouring Southeast Asian countries.
Zixin explains that this joint venture is part of the company&rsquo s strategic expansion plans in overseas markets.
AANDJ Group is an unrelated third-party Singapore-based company, which focused on consultancy, trade, and strategic business development, with particular involvement in fresh produce supply chains, market operations, and digitalisation initiatives.
Pursuant to the joint venture agreement, Zixin&rsquo s wholly-owned subsidiary will own 70% of the joint venture company while AANDJ Group will own the remaining 30%.
Zixin&rsquo s board believe that the joint venture will allow the company to have immediate access to AANDJ Group&rsquo s affiliated distribution platforms to market and distribute fresh produce and expands its sales revenue in overseas markets with fresh agricultural products.
Zixin highlights that the joint venture is not expected to have any material impact on its consolidated net tangible assets or earnings per share for the financial year ending March 31, 2027.
Compare the full throated write up on the SGD7k investment in JV with this SGD516,000 investment to a US co with scant record etc.
Page 3 of 4
(iv) Expansion into retail and distribution of high-quality health supplement products in the
United States through a strategic investment In December 2025, Zixin Group entered the US markets through a strategic investment in Zixin Life LLC (formerly known as PYUUIR Beauty Products, LLC) (&ldquo Zixin Life&rdquo ). Zixin Group&rsquo s wholly-
owned subsidiary, Zixin International Pte. Ltd., made a capital contribution of USD 400,000
(equivalent to SGD 516,000) (&ldquo Subscription Consideration&rdquo ) to Zixin Life in exchange for
membership interest, representing a 40% interest1 in Zixin Life post-injection.
Zixin Life is in the business of retail and distribution of health supplement products, along with
food and cosmetic products, in the United States.
The Subscription Consideration for the membership interest was arrived at after arms&rsquo length
negotiations between the parties on a willing-buyer willing-seller basis, after taking into
consideration, inter alia, the capital of Zixin Life. The Subscription Consideration was satisfied
wholly in cash at completion. The Subscription Consideration was funded by the net proceeds
of the exercise of share options as announced on 27 November 2025 and is not expected to
have any material impact on the earnings per share and net tangible assets per share of the
Company and the Group for the current financial year ending 31 March 2026 (&ldquo FY26&rdquo ).
Zixin Life was incorporated in June 2024 but has not commenced operations. The book value
and net tangible assets value of Zixin Life (pre-injection) is nil. No valuation of the Zixin Life has been commissioned by the Company.
Page 3 of 4
(iv) Expansion into retail and distribution of high-quality health supplement products in the
United States through a strategic investment In December 2025, Zixin Group entered the US markets through a strategic investment in Zixin Life LLC (formerly known as PYUUIR Beauty Products, LLC) (&ldquo Zixin Life&rdquo ). Zixin Group&rsquo s wholly-
owned subsidiary, Zixin International Pte. Ltd., made a capital contribution of USD 400,000
(equivalent to SGD 516,000) (&ldquo Subscription Consideration&rdquo ) to Zixin Life in exchange for
membership interest, representing a 40% interest1 in Zixin Life post-injection.
Zixin Life is in the business of retail and distribution of health supplement products, along with
food and cosmetic products, in the United States.
The Subscription Consideration for the membership interest was arrived at after arms&rsquo length
negotiations between the parties on a willing-buyer willing-seller basis, after taking into
consideration, inter alia, the capital of Zixin Life. The Subscription Consideration was satisfied
wholly in cash at completion. The Subscription Consideration was funded by the net proceeds
of the exercise of share options as announced on 27 November 2025 and is not expected to
have any material impact on the earnings per share and net tangible assets per share of the
Company and the Group for the current financial year ending 31 March 2026 (&ldquo FY26&rdquo ).
Zixin Life was incorporated in June 2024 but has not commenced operations. The book value
and net tangible assets value of Zixin Life (pre-injection) is nil. No valuation of the Zixin Life has been commissioned by the Company.
Secured a renewed order for probiotic-infused fermented sweet potato feedstock with Liancheng County Guanhe White Duck Family Farm
SAC Capital flags Zixin Group' s circular economy prospects
SAC Capital has issued a non-rated report on Zixin Group, touting its " circular economy" business model that can help insulate the structurally insulates sweet potato-based foodstuffs company from the
intense price wars plaguing downstream other Chinese retail competitors.
Besides its home base Liancheng country of Fujian, the company is setting up a similar sweet potato cultivating and processing ecosystem in Hainan with a landmass five times larger.
With the initial phases of land preparation already completed across multiple villages, this Hainan project is anticipated to begin contributing substantially to Zixin' s bottom line by FY2027 ending March 2027 to eventually double the company' s overall profitability, state SAC analysts Matthias Chan and Liu Maorong.
In addition, Zixin has set up a trading entity sited within the Hainan Free Trade Port.
By doing so, Zixin can tap " highly advantageous" zero tariff policies, significantly reducing tax liabilities on the import of raw materials and the export of processed goods.
From largely domestic sales thus far, Zixin is actively developing new markets such as Indonesia and the US.
Meanwhile, at its home base of Liancheng, the company is prepping the first phase of its new 86,000-square-metre high tech manufacturing facility which can eventually increase processing capacity by 2.6 times to 35,000 tonnes per year.
This capacity is specifically dedicated to the production of advanced functional ingredients, and not lower value sweet potato-based snacks.
" By targeting the lucrative, high-barrier business-to-business (B2B) functional food, bakery, and nutraceutical markets, Zixin is structurally elevating its gross profit margins far beyond the natural limitations of the competitive traditional consumer snack food sector," note Chan and Liu.
Zixin has been developing an animal feedstock business, which draws upon sweet potato skin and other ingredients left over from the processing of foodstuffs. This means Zixin is able to build up a circular economy.
It has secured key supply agreements and is well poised to secure additional orders for the animal feed.
In its most recent FY2026 earnings jumped 105.5% y-o-y to RMB16.1 million in 1HFY2026 ended Sept 2025, on the back of a 40.8% gain in revenue to RMB220.6 million.
As a rough gauge, Chan and Liu point out that Zixin is now trading at a P/E of 5.3x. In contrast, the mean valuation of the Catalist board is 15.8x.
$32k to him is peanuts but still good gesture with some skin in the game. At current price the downside risk is minimal unless Zixin goes belly up?
Bought some @ 3c & treated it as FD. Mentally prep it may not go anywhere within this period. Will only revisit once is a 5x, 10x bagger.
Just vested.
Bought some @ 3c & treated it as FD. Mentally prep it may not go anywhere within this period. Will only revisit once is a 5x, 10x bagger.
Just vested.
Zixin Group chairman adds shares as operations and earnings build up
On Mar 18, Liang Chengwang, executive chairman and CEO of biotechnology company Zixin Group, acquired one million shares via a market transaction for S$32,000.
This lifted his deemed interest from 13.66 per cent to 13.71 per cent, or 275.6 million shares, held through nominees including CGS International Securities and Bank of Singapore.
Liang leads the sweet potato-focused group&rsquo s overall strategy, business operations and corporate development. His oversight includes major financing initiatives and senior executive appointments.
He is also a co-founder of Fujian Zixin Biotechnological Sweet Potato Co and has deep operating experience in sweet potato food products, including as general manager of Liancheng Tianhe Food Factory.
On Feb 6, Zixin Group updated its shareholders on operational progress across feedstock, food ingredients, branded products and overseas expansion.
It said it renewed a probiotic-infused fermented sweet potato feedstock order with a local poultry farm. This renewed order, while maintaining the same selling price, resulted in a 50 per cent increase in annual quantity demand &ndash it rose from 1,080 tonnes in 2025 to 1,620 tonnes for 2026.
The group also commenced commercial production of Zixin CellRootZ+, a single-cell sweet potato powder, in January. This followed trial production in the fourth quarter of 2025, with initial orders coming from noodle manufacturers and bakeries in Fujian.
In parallel, Zixin Group expanded outsourced snack production to support a shift towards higher-margin branded sweet potato products, including crisps and vacuum-packed offerings.
Separately, it entered the US market through a US$400,000 strategic investment for a 40 per cent stake in Zixin Life, a health supplement and consumer products platform.
While the board noted no material impact on FY2026 results, it highlighted these initiatives as drivers of longer-term organic growth.
Last November, it reported that its H1 FY2026 (ended Sep 30, 2025) revenue rose 40.8 per cent year on year to 220.6 million yuan (S$40.9 million). Net profit, meanwhile, more than doubled to 16.1 million yuan.
The group cited support from broad-based growth across cultivation, processed foods, as well as recovery-and-recycling activities.
Processed sweet potato products accounted for over 70 per cent of group revenue, while the recovery-and-recycling segment began generating contributions from probiotic-infused fermented feedstock.
The company&rsquo s gross margin eased to 30.2 per cent due to higher raw material costs and capacity expansion overheads, though its balance sheet strengthened, with net cash rising to 187.7 million yuan as at Sep 30.
Lim & Tan Securities maintained its &ldquo buy&rdquo call on Zixin Group&rsquo s stock following a site visit and review of the H1 FY2026 results. While the brokerage&rsquo s report noted that margins remained under pressure from higher input costs and underutilisation of a new high-tech facility, it upgraded its FY2026 net profit forecast to 70 million yuan.
It based this projection on stronger utilisation in H2 FY2026, higher-value processed and original equipment manufacturer products, operating efficiency gains, and potential upside from premium sweet potato powder.
CEO bought1 million shres at $0.032 on 18 Mar
https://links.sgx.com/1.0.0/corporate-announcements/MDN58845JBJWS9FD/878669__Form%201%20-%20LCW.pdf
https://links.sgx.com/1.0.0/corporate-announcements/MDN58845JBJWS9FD/878669__Form%201%20-%20LCW.pdf
Managed to change course when Israel started to bomb Iran. Unloaded almost two-third of my holding at 0.032. Profit drastically reduced but at least not into the red.
i am still waiting to collect @ 0.032
This stock will fly like a rocket in a few months time.
This stock will fly like a rocket in a few months time.
Here is a summary of the Zixin Group operations update, highlighting key developments and their benefits:
---
Zixin Group Operations Update &ndash Summary of Benefits
1. Renewed & Expanded Feedstock Contract
· Benefit: Secured a 50% increase in annual order volume for probiotic-infused fermented sweet potato feedstock from a local poultry farm.
· Financial Impact: Expected 2026 revenue of RMB 4.86 million (&asymp SGD 0.89 million), up from RMB 3.24 million in 2025.
2. Launch of Advanced Food Ingredient &ndash Zixin CellRootZ+&trade
· Benefit: Introduction of a high-nutrient, single-cell sweet potato powder using advanced extraction technology for better nutrient retention.
· Progress:
· Trial production in Q4 2025, with samples sent to noodle and bakery manufacturers.
· Commercial production began in January 2026, fulfilling initial orders from Fujian-based businesses.
· Strategic Benefit: Demonstrates biotechnology capability and creates a new revenue stream.
3. Expansion in Hainan &ndash Snack Product Manufacturing
· Benefit: Two purchase orders totaling RMB 9.78 million (&asymp SGD 1.79 million) for sweet potato snacks (dried strips and fries) through third-party factories.
· Goal: Shift production toward higher-margin products, including:
· Sweet potato crisps
· Additive-free vacuum-packed steamed sweet potato
· BBQ vacuum-packed sweet potato
· Single-cell sweet potato powder
4. Strategic Entry into U.S. Market
· Benefit: Acquired a 40% stake in Zixin Life LLC, a U.S.-based retailer and distributor of health supplements, food, and cosmetics.
· Investment: USD 400,000 (&asymp SGD 516,000) funded through share option proceeds.
· Strategic Benefit: Provides a platform for retail and distribution expansion in the U.S., leveraging Zixin&rsquo s health-focused product lines
i suggest u dont waste capital on this counter.. there alot alot more worth investing ones..
This dont give dividends as well. if things dont turn out good it might go back to high 10s again.
DYODD
This dont give dividends as well. if things dont turn out good it might go back to high 10s again.
DYODD
Wesley ( Date: 20-Jan-2026 13:26) Posted:
|
Waiting to grab some @ 0.034
Hope he will park more in Trendlines.
he park his money in this lousy company useless.. can bring to somewhere else and grow.. park so long only make 0.006..
get out before he sells everything
DYODD
get out before he sells everything
DYODD
LoudShout ( Date: 19-Jan-2026 08:41) Posted:
|